Somatostatin, a peptide isolated from ovine hypothalamic tissue that inhibits the release of radioimmunoassayable growth hormone in vitro from rat or human pituitary cells or in vivo in rats, has the primary structure H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-LysThr-Phe-Thr-Ser-Cys-OH. The structure was established by submitting the carboxymethylated peptide, the carboxymethylated tryptic digest, and the chymotryptic digest of the peptide to Edman degradation. Degradation products were analyzed by amino-acid analysis, as well as in some cases by determination of N-termini by dansylation or by determination of phenylthiohydantoins by mass spectrometry.
We have recently reported the isolation from (sheep) hypothalamic extracts of a peptide that specifically inhibits at ) 1 nM the in vitro secretion of immunoreactive rat or human growth hormones, and that is similarly active in vivo in rats (1) . This peptide will be referred to as somatostatin (see ref.
1). We report here details of the determination of the primary sequence of this peptide.
MATERIALS AND METHODS
The starting material was a side fraction obtained from the purification of extracts of sheep hypothalamic fragments for the characterization of the releasing factors of the gonadotropins, in a program similar to that previously described for luteinizing hormone-releasing factor (LRF) (2) . Details of the isolation procedure will be published elsewhere (Brazeau et al., in preparation). In summary, an ethanol-chloroformacetic acid-water 810:100:5:90 extract of about 500,000 sheep hypothalamic fragments (2 kg) was partitioned in the system 0.1% acetic acid-n-butyl alcohol-pyridine 11:5:3, and the material from the organic phase was then partitioned in n-butyl alcohol-acetic acid-water 4: 1: 5. The aqueous phase from the second distribution was subjected to ion-exchange chromatography on carboxymethyl-cellulose, whereupon a basic fraction with somatostatin activity was well separated from the luteinizing hormone-releasing factor zone. The biologically active fraction was further purified by gel filtration on "Sephadex G-25" in 0.5 M acetic acid (RF of somatostatin = 0.5), and finally by liquid partition chromatography (3) on a "Sephadex G-25" support in n-butyl alcohol-acetic acid-water 4:1:5 (RF = 0.4). The final product, 8 .5 mg, contained 75% amino acids by weight, and showed only traces of peptide impurities upon thin-layer chromatography and electrophoresis.
Papain, leucine aminopeptidase, a-chymotrypsin (3-times crystallized), and crystalline trypsin (treated with L-[tosylamido-2-phenyl]ethyl chloromethyl ketone, as in ref. 4) were obtained from Worthington. Reagents were reagent or analytical grade.
Amino-Acid Analysis. Peptides were hydrolyzed in 200 ,ul of 6N HCl-0.5% thioglycollic acid (5) or 50 ,l of 3N p-toluenesulfonic acid containing 0.2% 3-(2-aminoethyl)-indole (6 (11) with a few modifications: coupling with phenylisothiocyanate (PITC) was done with 5% dimethylallylamine in 50% pyridine, adjusted to pH 9.5 with trifluoroacetic acid. Because of difficulties due to the hydrophobic nature of the peptide, it was necessary to reduce the extent of the butylacetate extraction procedure in these experiments. After the first Edman degradation cycle (coupling and cleavage) of 1.8 mg of carboxymethylated somatostatin, the partially degraded peptide was suspended in 150 MAI of 0.5 M pyridine acetate buffer (pH 6.5) and extracted with 0.5 ml of n-butylacetate (containing 50 Ml/liter of dithioethane). After centrifugation, most or all of the peptide was found suspended in the aqueous phase, insoluble in both phases. The precipitate was combined with 150 Al of buffer wash of the butylacetate phase and lyophilized. The residue was dissolved in 50% pyridine-5% dimethylallylamine buffer, in which it was soluble, for the next Edman cycle. This procedure was repeated until the 5th Edman cycle, whereupon the residual degraded peptide became soluble in butylacetate. An equal volume of cyclohexane was added to the butylacetate phase to precipitate the peptide, which was combined with the residue to the aqueous phase for the next cycle. In the 6th Edman cycle, the buffer suspension of peptide (150 Al) was extracted with 0.5 ml of 1:1 (v/v) cyclohexane-butylacetate. After the 7th Edman cycle, the peptide partitioned completely into the butylacetate phase (Table 1 ) when equal volumes of buffer and butylacetate were shaken together; the 8th Edman degradation was, therefore, performed on the butylacetate phase. After the 9th Edman cycle, the peptide again started to partition into the aqueous phase, so this and subsequent degradation cycles were performed by the extraction procedure de- scribed for the 1st cycle; thus, 150 ,l of buffer was extracted with 0.5 ml of butylacetate, and the butylacetate was washed with 150 Ml of buffer.
The mixtures of peptides in the tryptic or chymotryptic digests were sequenced according to the method described for the first cycle above. Contents of each of the butylacetate phases and each of the aqueous phases from the carboxymethylated tryptic digest were sequenced. Because some of the difficulties in sequencing the intact peptides may have been due to incomplete coupling of PITC with the peptide (see Results and Discussion), 5 Mll of neat PITC was added after the usual 1 hr of coupling and incubation was continued for an additional hour during the sequencing of the carboxymethylated trypsin digest.
Aliquots were taken for amino-acid analysis, as well as for analysis by the dansyl end-group method with 14C-labeled dansyl derivatives (11) , and for direct determination of Pthderivatives by mass spectrometry as described below. Control samples of each enzyme were carried through the sequencing procedures.
Mass Spectrometry. Silylated Pth-derivatives were determined by gas chromatography-mass spectrometry as described (11) . Some of the 2-anilino-thiazolinone derivatives were analyzed by mass spectrometry with a direct inlet system.
The thiazolinone derivatives need not be converted to the corresponding thiohydantoins because they undergo thermal rearrangement to the thiohydantoin from the heat of the probe during mass spectrometric analysis (12) . The temperature of the probe was slowly increased to boil off the excess PITC until the molecular ion of the Pth-derivative was observed.
Digestion (15) . The remaining aliquot (180 nmol) was subjected to sequencing by Edman degradation as described above.
Determination of C Termini. C-Terminal amino acids were determined by hydrazinolysis and dansylation (11) .
RESULTS AND DISCUSSION
Analysis of amino acids obtained from somatostatin after acid hydrolysis in 6 N HCl-0.5% thioglycollic acid gave the molar S-S ratios Ala (0.9), Gly (1. [6] [7] [8] [9] . The 8th Edman cycle was performed on the products in the butylacetate fraction, 7B, and the 9th cycle on fraction 8B; the other sequencing reactions were done on the water-soluble fractions (see text). ¶ Unhydrolyzed. mixed disulfide arising from cysteine and mercaptoethanol (13) in the buffer used in the enzymic hydrolysis. Using the color value for cystine, 2 mol of total cysteine residues per mol of peptide were calculated, but no conclusion could be drawn about the state of oxidation of the sulfur in the analytical samples because it was altered by the hydrolysis reagents. However 5-10. Therefore, the partial sequences: H-Ala-Gly-Cys-Lys-Asn-(Phe, Phe, Trp, Lys)-Thr-Phe-(Thr, Ser)-Cys-OH or Ala-GlyCys-Lys-Asn-Phe-(Phe, Lys)-Thr-Phe-(Trp, Thr, Ser)-Cys-OH (with Trp being subtracted in the 13-15 cycle) can be proposed. Dansyl end-group analysis confirmed the N-terminal sequence Ala-Gly-Cys-Lys-Asx-Phe-(Phe, X)-Lys-(X denotes that no amino acid was identified), and mass spectrometry revealed Pth-derivatives of Ala, Gly, Cys, Lys, Asn, and Phe in cycles 1-6, respectively. Beyond the eighth cycle, evaluation by the dansyl end-group procedure became impossible because of the low recovery of peptide, and because in the aliquots required, residual reagents interfered with the analysis. An unidentified oil residue that was not extractable by butylacetate was particularly trouiblesome. This product may result from the use of dimethylallylamine buffer in silylated glassware (14) . Mass spectrometric analysis also was difficult because of the inefficient extraction of thiazolinone under these conditions and because of the small amount of peptide remaining in the last cycles. The appearance of Cys-(Cm) in the unhydrolyzed sample from the last Edman cycle while no Cys(Cm)-NH2 (retention time = 167 min) was found confirms that the C-terminus is the free acid.
After trypsin digestion of somatostatin followed by carboxymethylation, dansylation showed Ala, Asx, and Thr as N-termini; hydrazinolysis-dansylation of the products yielded Lys and Cys(Cm) as C-termini. Sequencing by Edman degradation of the carboxymethylated trypsin digest as followed by subtractive amino-acid analysis, dansylation, and mass spectrometry gave the results shown in Tables 2 and 3 .
With the foregoing data and that of Tables 2 and 3 , we can conclude that trypsin digestion resulted in three peptide fragments. The amino-terminal sequence previously obtained from the results of sequencing the intact carboxymethylated peptide (see above) has been established as H-Ala-Gly-CysLys-Asn-Phe-; hence, the fragment T1, Ala-Gly-Cys-Lys- (Fig. 1) would be expected from a tryptic cleavage of the Nterminus. This result accounts for the subtraction of Ala, Gly, Cys(Cm), and Lys in Edman cycles 1-4 of the water-soluble materials of the trypsin digest (Table 2) . Another fragment was extracted into the butylacetate phase after the first Edman degradation, accounting for the loss of 2 Phe, 1 Lys, and possibly 1 Trp from the aqueous phase (Tables 2 and 3 ).
The third peptide fragment (Table 2 ) could, therefore, be identified in the aqueous phase as having the sequence ThrPhe-Thr-Ser-Cys-OH (T;, Fig. 1 ). The appearance of free Cys(Cm) rather than Cys(Cm)-NH2 in the unhydrolyzed sample of the 4th Edman cycle confirms that the C-terminus is a free acid. The results of dansylation analysis and direct determination of Pth-derivatives (Table 2) are also compatible with structures assigned to peptides T1 and T3. The data in Table 3 show that a tetrapeptide, -Phe-Phe-X-Lys-was extracted by butylacetate after the 1st Edman cycle, since C-terminal Lys as dansyl-(E-Ptc)Lys was found in the unhydrolyzed aliquot after the 4th Edman cycle. A failure in the coupling (or cleavage) reaction in the 3rd cycle was ruled out since the subtractive method shows a removal of Phe in that cycle and since no dansyl-Phe was found (high Phe values in the analyses after the 2nd and 3rd cycles probably result from the hydrolysis of Pth-Phe; this derivative would also be blocked to the dansyl reaction). Since all the other amino acids present in the analysis of the intact peptide have been accounted for, it can be presumed that the unidentified aminoacid residue in the third position was Trp, and that the peptide fragment T2 (Fig. 1) is -Asn-Phe-Phe-Trp-Lys-, thereby establishing the primary sequence of somatostatin as that shown in Fig. 1 . In confirmation of the location of the Trp, mass spectrometric analysis of the acetylated permethylated peptide from the trypsin digest showed the presence of a fragment with the sequence -Asn-Phe-Phe-Trp-Lys- (15) . The results of sequencing the products of chymotrypsin digestion of somatostatin (Table 4) are also compatible with the sequence shown in Fig. 1 , chymotryptic cleavages yielding primarily the fragments Chi, Ch2, Ch3, and Oh4, with smaller amounts of free Phe and Trp. SH The linear tetradecapeptide H-Ala-Gly-Cys-Lys-Asn-Phe-SH Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH was synthesized by solid-phase methodology and converted to the oxidized form ( Fig. 1) 
